COVID-19: gastrointestinal and hepatobiliary manifestations
AR Shih, J Misdraji - Human Pathology, 2023 - Elsevier
SARS-CoV-2 is the viral agent of COVID-19, a pandemic that surfaced in 2019. Although
predominantly a respiratory ailment, patients with COVID-19 can have gastrointestinal (GI) …
predominantly a respiratory ailment, patients with COVID-19 can have gastrointestinal (GI) …
Unraveling the molecular and cellular pathogenesis of COVID-19-associated liver injury
H Akkiz - Viruses, 2023 - mdpi.com
The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory
syndrome coronavirus (SARS-CoV-2) continues to cause substantial morbidity and mortality …
syndrome coronavirus (SARS-CoV-2) continues to cause substantial morbidity and mortality …
COVID‐19‐associated cholangiopathy: What is left after the virus has gone?
N Heucke, V Keitel - Hepatology, 2022 - journals.lww.com
Hepatic interferon regulatory factor 8 expression suppresses... : Hepatology Hepatic interferon
regulatory factor 8 expression suppresses hepatocellular carcinoma progression and enhances …
regulatory factor 8 expression suppresses hepatocellular carcinoma progression and enhances …
Clinical characteristics of patients infected with novel coronavirus wild strain, Delta variant strain and Omicron variant strain in Quanzhou: a real‑world study
H Zhang, W Chen, X Ye, Y Zhou… - Experimental and …, 2022 - spandidos-publications.com
This study aimed to investigate the clinical features of patients infected with novel
coronavirus wild strains, Delta variant strains and Omicron variant strains to provide a …
coronavirus wild strains, Delta variant strains and Omicron variant strains to provide a …
Secondary sclerosing cholangitis after SARS-CoV2: ICU ketamine use or virus-specific biliary tropism and injury in the context of biliary ischemia in critically ill patients …
A Bartoli, C Cursaro, H Seferi… - … Medicine: Evidence and …, 2023 - Taylor & Francis
Purpose From the beginning of the Severe Acute Respiratory Syndrome CoronaVirus-2
(SARS-CoV2) pandemic, different cases of a cholangiopathy with features of secondary …
(SARS-CoV2) pandemic, different cases of a cholangiopathy with features of secondary …
Liver organoids: From fabrication to application in liver diseases
Q Liu, A Zeng, Z Liu, C Wu, L Song - Frontiers in Physiology, 2022 - frontiersin.org
As the largest internal organ, the liver is the key hub for many physiological processes.
Previous research on the liver has been mainly conducted on animal models and cell lines …
Previous research on the liver has been mainly conducted on animal models and cell lines …
Bioengineering liver organoids for diseases modelling and transplantation
Organoids as three-dimension (3D) cellular organizations partially mimic the physiological
functions and micro-architecture of native tissues and organs, holding great potential for …
functions and micro-architecture of native tissues and organs, holding great potential for …
[HTML][HTML] 肝脏类器官研究的文献计量学分析
徐灿丽， 何文星， 汪磊， 吴芳婷， 王佳慧， 段雪琳… - 中国组织工程研究, 2024 - cjter.com
肝脏类器官研究的文献计量学分析 中国组织工程研究 首页 关于本刊 编委会 在线投稿 期刊公告
出版道德 OA政策 作者学院 在线问答 联系我们 English 中国组织工程研究 ›› 2024, Vol. 28 ›› …
出版道德 OA政策 作者学院 在线问答 联系我们 English 中国组织工程研究 ›› 2024, Vol. 28 ›› …
[HTML][HTML] Liver injury in COVID-19: A minireview
WS Hu, FY Jiang, W Shu, R Zhao, JM Cao… - World Journal of …, 2022 - ncbi.nlm.nih.gov
Abstract Coronavirus disease 2019 (COVID-19), caused by infection with the severe acute
respiratory syndrome coronavirus-2 (SARS-CoV-2), has escalated into a global tragedy …
respiratory syndrome coronavirus-2 (SARS-CoV-2), has escalated into a global tragedy …
COVID‐19 and non‐alcoholic fatty liver disease: Biological insights from multi‐omics data
CJ Pirola, S Sookoian - Liver International, 2023 - Wiley Online Library
We explored the shared pathophysiological mechanisms between COVID‐19 and non‐
alcoholic fatty liver disease (NAFLD) by integrating multi‐omics data. We studied common …
alcoholic fatty liver disease (NAFLD) by integrating multi‐omics data. We studied common …